Cullinan Therapeutics Statistics
NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.89-0.18 (-1.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cullinan Therapeutics by the numbers
Cullinan Therapeutics has a market capitalization of $577.1 million based on 64.92M shares outstanding. With trailing EPS of $-3.09, Cullinan Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.3% below its 50-day average and 43.5% below its 200-day average.
Average daily trading volume is 997.14K shares, or about $8.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGEM valuation vs. peer median
| Metric | CGEM | Peer median | Difference |
|---|---|---|---|
| Market cap | $577.15M | $576.14M | +0% |
| Avg. volume | 997.14K | 487.75K | +104% |
Peer median across 8 companies: SRZN, FDMT, ENTX, DBVT, IAM, ETRA, VALN, ATTO.
Valuation
- Market cap
- $577.15M
- EPS (TTM)
- $-3.09
- Shares outstanding
- 64.92M
Price and trading
- Previous close
- 9.07
- Open
- 8.84
- Day range
- 8.80 – 9.43
- 52-week range
- 8.47 – 23.19
- 52-week change
- -6.12%
- Beta
- —
- Volume
- 1.01M
- Average volume
- 997.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 577.15M
- Forward Pe
- -3.85
- Eps
- -3.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.19
- Week52 Low
- 8.47
- Avg Volume
- 997.14K
- Shares Outstanding
- 64.92M
- Ma50
- 14.65
- Ma200
- 15.74
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -61.66%
- Pct From52w Low
- 4.96%